Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Cost-utility analysis of treatments for stage IB cervical cancer.

Katanyoo K, Praditsitthikorn N, Tangjitgamol S, Manusirivithaya S, Supawattanabodee B.

J Gynecol Oncol. 2014 Apr;25(2):97-104. doi: 10.3802/jgo.2014.25.2.97. Epub 2014 Apr 9.

PMID:
24761212
[PubMed]
Free PMC Article
2.

Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.

Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP.

Gynecol Oncol. 2005 Feb;96(2):490-5.

PMID:
15661240
[PubMed - indexed for MEDLINE]
3.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

PMID:
17999840
[PubMed - indexed for MEDLINE]
Free Article
4.

Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.

Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T.

Int J Gynecol Cancer. 2013 Mar;23(3):567-75. doi: 10.1097/IGC.0b013e31828703fd.

PMID:
23385284
[PubMed - indexed for MEDLINE]
5.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

PMID:
16904047
[PubMed - indexed for MEDLINE]
Free Article
6.

Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.

Kobayashi Y, Ohara T, Wada Y, Okuda Y, Kondo H, Okuma Y, Suzuki N, Gomi H, Kiguchi K, Ishizuka B.

J Obstet Gynaecol Res. 2009 Jun;35(3):490-4. doi: 10.1111/j.1447-0756.2008.00955.x.

PMID:
19527388
[PubMed - indexed for MEDLINE]
7.

Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer.

Hayman JA, Hillner BE, Harris JR, Weeks JC.

J Clin Oncol. 1998 Mar;16(3):1022-9.

PMID:
9508186
[PubMed - indexed for MEDLINE]
8.

The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.

Pandor A, Eggington S, Paisley S, Tappenden P, Sutcliffe P.

Health Technol Assess. 2006 Nov;10(41):iii-iv, xi-xiv, 1-185. Review.

PMID:
17049138
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

PMID:
17999842
[PubMed - indexed for MEDLINE]
Free Article
11.

Hormonal therapies for early breast cancer: systematic review and economic evaluation.

Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L.

Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. Review.

PMID:
17610808
[PubMed - indexed for MEDLINE]
Free Article
12.

Cost effectiveness of darunavir/ritonavir in highly treatment-experienced, HIV-1-infected adults in the USA.

Mauskopf J, Brogan A, Martin S, Smets E.

Pharmacoeconomics. 2010;28 Suppl 1:83-105. doi: 10.2165/11587470-000000000-00000.

PMID:
21182346
[PubMed - indexed for MEDLINE]
13.

Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(27):1-118. Epub 2010 Dec 1.

PMID:
23074405
[PubMed]
Free PMC Article
14.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

PMID:
16904046
[PubMed - indexed for MEDLINE]
Free Article
15.

Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.

Haentjens P, De Groote K, Annemans L.

Arch Orthop Trauma Surg. 2004 Oct;124(8):507-17. Epub 2004 Sep 10.

PMID:
15365714
[PubMed - indexed for MEDLINE]
16.

Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.

Lee YY, Park W, Huh SJ, Yoon A, Park JY, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.

Anticancer Res. 2013 Oct;33(10):4675-81.

PMID:
24123048
[PubMed - indexed for MEDLINE]
17.

A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.

Retèl VP, van der Molen L, Hilgers FJ, Rasch CR, L'Ortye AA, Steuten LM, van Harten WH.

BMC Cancer. 2011 Nov 3;11:475. doi: 10.1186/1471-2407-11-475.

PMID:
22051143
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Cost effectiveness of risk-prediction tools in selecting patients for immediate post-prostatectomy treatment.

Zubek VB, Konski A.

Mol Diagn Ther. 2009;13(1):31-47. doi: 10.2165/01250444-200913010-00006.

PMID:
19351214
[PubMed - indexed for MEDLINE]
19.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
20.

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer.

Garrison LP Jr, Lubeck D, Lalla D, Paton V, Dueck A, Perez EA.

Cancer. 2007 Aug 1;110(3):489-98.

PMID:
17592827
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk